Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have persistent or permanent atrial fibrillation (an irregular heart rhythm that does not go away on its own)
- People whose heart rate is controlled, with a resting heart rate of 100 beats per minute or lower
- People who are able to complete an exercise test that pushes them to their limit of comfort
- People who are 40 years of age or older
Who may not be able to join:
- People who are already doing regular exercise training more than twice a week
- People who have unstable angina (chest pain that is unpredictable or getting worse)
- People who have been diagnosed with severe narrowing of the mitral or aortic heart valves
- People who have been diagnosed with a specific type of thickened heart muscle condition (hypertrophic obstructive cardiomyopathy) that causes significant blockage of blood flow
- People who are pregnant, breastfeeding, or planning to become pregnant during the study
- People who are not able to provide written agreement to take part in the trial
- People who are unwilling or unable to attend a follow-up appointment at 12 weeks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jennifer L Reed, PhD, Ottawa Heart Institute Research Corporation
Phone: 613-696-7392
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in quality of life measured by the physical component summary (PCS) measure of the Short Form 36 Health Survey Questionnaire (SF-36).; Changes in exercise capacity measured by VO2peak on a symptom-limited cardiopulmonary exercise test (CPET).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.